维普中文期刊产品整合服务
13篇 您的检索式:作者名="Nancy F B"
    题名 作者 年代 出处 被引量
1Preoperative transcatheter closptal defects of congenital muscular ventricular septal defects 显示文摘BRIDGES NANCY D PERRY STANTON B KEANE JOHN F 1991N Eng Med1991,324,:1
2Global change and the ecology of cities 显示文摘Nancy B G Stanley H F Nancy E G 2008Science2008,319,:1
3Glassy carbon electrodes modified with CNT dispersed in chitosan: Analytical applications for sensing DNA -methylene blue interaction显示文摘PAULINA A NANCY F FERREYRA GUSTAVO A RIVAS SOLEDAD B 2009J Electroanal Chem2009,634,8:1
4Energy requirements during pregnancy based on total energy expenditure and energy deposition1,2,3,4显示文摘Nancy F B William W W Margarita S T 2004American Journal of Clinical Nutrition2004,79,6:1
5Improvement of in vitro culturing of habanero pepper by inhibition of ethylene effects 显示文摘Nancy S B Adriana C F Lourdes G 2006Hortscience2006,41,2:1
6Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
7Does assisted hatching pose a risk for monozygotic twinning in pregnancies conceived through in vitro fertilization?显示文摘Laura A Schieve Susan F Meikle Herbert B Peterson Gary Jeng Nancy M Burnett Lynne S Wilcox 2000Fertility and Sterility2000,,2:1
8Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus 显示文摘Nancy F B 2000Am J Clin Nutr2000,71,5:1
9Prevention of pediatric overweight and obesity显示文摘Nancy F K Marc S J Robert D B 2003Pediatrics2003,112,:1
10Assessing physical activity using wearable monitors: measures of physical activity显示文摘NANCY F B ULF E KLAAS R W 2012Med Sci Sports Exe2012,44,1:1
11Composi- tion of gestational weight gain impacts maternal fat retention and infant birth weight 显示文摘NANCY F B KENNETH J E WILLIAM W W 2003Am J Obstet Gynecol2003,189,5:1
12Relationship of Malocclusion Severity and Treatment Fee to Consumer's Expectation of Treatment outcome显示文摘Joseph P John F Nancy W B 2003Am J Orthod Dentofical Orthop2003,124,:1
13Analyzing Landslip Ha- zards with GIS Technology 显示文摘MICHAEL A F NANCY R B 1989Public Works1989,120,13:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费